RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Twist Bioscience Stock

Twist Bioscience Revenue 2024

Twist Bioscience Revenue

317.15 M USD

Ticker

TWST

ISIN

US90184D1000

WKN

A2N7L2

In 2024, Twist Bioscience's sales reached 317.15 M USD, a 29.4% difference from the 245.1 M USD sales recorded in the previous year.

The Twist Bioscience Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e782.7511,46
2028e609.4514,72
2027e526.2217,05
2026e459.8619,51
2025e380.6523,56
2024e317.1528,28
2023245.136,60
2022203.641,36
2021132.339,08
202090.131,85
201954.412,87
201825.4-26,77
201710.8-123,15
20162.3-313,04

Twist Bioscience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Twist Bioscience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Twist Bioscience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Twist Bioscience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Twist Bioscience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Twist Bioscience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Twist Bioscience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Twist Bioscience’s growth potential.

Twist Bioscience Revenue, EBIT and net profit per share

DateTwist Bioscience RevenueTwist Bioscience EBITTwist Bioscience Net Income
2029e782.75 M undefined0 undefined0 undefined
2028e609.45 M undefined-76.09 M undefined-69.32 M undefined
2027e526.22 M undefined-109.65 M undefined-103.99 M undefined
2026e459.86 M undefined-126.49 M undefined-108.24 M undefined
2025e380.65 M undefined-159.79 M undefined-144.33 M undefined
2024e317.15 M undefined-190.45 M undefined-211.67 M undefined
2023245.1 M undefined-201 M undefined-204.6 M undefined
2022203.6 M undefined-234.8 M undefined-217.9 M undefined
2021132.3 M undefined-152.7 M undefined-152.1 M undefined
202090.1 M undefined-117.6 M undefined-139.9 M undefined
201954.4 M undefined-108.9 M undefined-107.7 M undefined
201825.4 M undefined-70.6 M undefined-71.2 M undefined
201710.8 M undefined-58.5 M undefined-59.3 M undefined
20162.3 M undefined-43.7 M undefined-44.1 M undefined

Twist Bioscience stock margins

The Twist Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Twist Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Twist Bioscience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Twist Bioscience's sales revenue. A higher gross margin percentage indicates that the Twist Bioscience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Twist Bioscience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Twist Bioscience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Twist Bioscience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Twist Bioscience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Twist Bioscience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Twist Bioscience Margin History

Twist Bioscience Gross marginTwist Bioscience Profit marginTwist Bioscience EBIT marginTwist Bioscience Profit margin
2029e36.6 %0 %0 %
2028e36.6 %-12.49 %-11.37 %
2027e36.6 %-20.84 %-19.76 %
2026e36.6 %-27.51 %-23.54 %
2025e36.6 %-41.98 %-37.92 %
2024e36.6 %-60.05 %-66.74 %
202336.6 %-82.01 %-83.48 %
202241.36 %-115.32 %-107.02 %
202139.08 %-115.42 %-114.97 %
202031.85 %-130.52 %-155.27 %
201912.87 %-200.18 %-197.98 %
2018-26.77 %-277.95 %-280.31 %
2017-123.15 %-541.67 %-549.07 %
2016-313.04 %-1,900 %-1,917.39 %

Twist Bioscience Aktienanalyse

What does Twist Bioscience do?

Twist Bioscience Corp is a company specializing in the production and applications of synthetic DNA. It was founded in 2013 and is based in San Francisco, California, USA. The company utilizes proprietary technologies to cost-effectively produce high-quality and high-quantity synthetic DNA. The company operates in three business areas: DNA synthesis, biopharmaceuticals, and data storage. The DNA synthesis division is the core of the company and involves the production of synthetic DNA for applications in various industries, including medicine, agricultural science, biotechnology, plastic engineering, and others. The company manufactures customized DNA synthesis products tailored to the needs of its customers, allowing them to accelerate and optimize their research and development projects. Twist Bioscience has also developed a proprietary technology called "Twist Biosensor" that enables rapid and cost-effective analysis of genetic variations. The biopharmaceutical division focuses on the development of therapeutics and diagnostics based on synthetic DNA. Twist Bioscience develops antibodies and proteins that can be used in cancer and immunotherapy, as well as diagnostics. In the data storage field, Twist Bioscience develops solutions for storing large amounts of data on DNA. This technology utilizes the dense and stable structure of DNA to securely and reliably store data in the long term. Twist Bioscience's DNA synthesis products are utilized by researchers, companies, and public institutions in various industries. Customers value not only the wide product portfolio but also the high quality and precision of the products, as well as the speed of order processing. The company operates a number of manufacturing facilities near its customers in Europe and Asia to ensure fast and efficient delivery of its products. This allows Twist Bioscience to have a strong position in the global market. In recent years, the company has achieved significant milestones. In 2018, Twist Bioscience went public and raised a total of $70 million through its IPO. The company has also established partnerships with various other companies and institutions to develop new applications and products. Overall, Twist Bioscience is a growing company specializing in the production and applications of synthetic DNA. With its wide range of high-quality and customized DNA synthesis products, as well as its innovative solutions in the biopharmaceutical and data storage sectors, the company has established a strong market position. Twist Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Twist Bioscience's Sales Figures

The sales figures of Twist Bioscience originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Twist Bioscience’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Twist Bioscience's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Twist Bioscience’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Twist Bioscience stock

How much revenue did Twist Bioscience generate this year?

Twist Bioscience has achieved a revenue of 317.15 M USD this year.

How much was the turnover of the company Twist Bioscience compared to the previous year?

The revenue of Twist Bioscience has increased by 29.4% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Twist Bioscience?

The revenue of Twist Bioscience is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Twist Bioscience measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Twist Bioscience so important for investors?

The revenue of Twist Bioscience is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Twist Bioscience pay?

Over the past 12 months, Twist Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Twist Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Twist Bioscience?

The current dividend yield of Twist Bioscience is .

When does Twist Bioscience pay dividends?

Twist Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Twist Bioscience?

Twist Bioscience paid dividends every year for the past 0 years.

What is the dividend of Twist Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Twist Bioscience located?

Twist Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Twist Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Twist Bioscience from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did Twist Bioscience pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of Twist Bioscience in the year 2023?

In the year 2023, Twist Bioscience distributed 0 USD as dividends.

In which currency does Twist Bioscience pay out the dividend?

The dividends of Twist Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Twist Bioscience stock can be added to a savings plan with the following providers: Scalable Capital

Andere Kennzahlen von Twist Bioscience

Our stock analysis for Twist Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Twist Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.